nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR7—coronary artery disease	0.269	0.665	CbGaD
Lurasidone—HTR2A—coronary artery disease	0.135	0.335	CbGaD
Lurasidone—HTR1A—Penbutolol—coronary artery disease	0.0776	0.309	CbGbCtD
Lurasidone—CYP3A4—Ticagrelor—coronary artery disease	0.0254	0.101	CbGbCtD
Lurasidone—CYP3A4—Fenofibrate—coronary artery disease	0.0227	0.0902	CbGbCtD
Lurasidone—CYP3A4—Gemfibrozil—coronary artery disease	0.0181	0.0721	CbGbCtD
Lurasidone—CYP3A4—Clopidogrel—coronary artery disease	0.0157	0.0625	CbGbCtD
Lurasidone—CYP3A4—Eplerenone—coronary artery disease	0.0146	0.0581	CbGbCtD
Lurasidone—CYP3A4—Enalapril—coronary artery disease	0.013	0.0518	CbGbCtD
Lurasidone—CYP3A4—Ezetimibe—coronary artery disease	0.0101	0.0403	CbGbCtD
Lurasidone—CYP3A4—Rosuvastatin—coronary artery disease	0.0101	0.0403	CbGbCtD
Lurasidone—CYP3A4—Simvastatin—coronary artery disease	0.00941	0.0374	CbGbCtD
Lurasidone—CYP3A4—Pravastatin—coronary artery disease	0.00921	0.0366	CbGbCtD
Lurasidone—CYP3A4—Lovastatin—coronary artery disease	0.00921	0.0366	CbGbCtD
Lurasidone—CYP3A4—Atorvastatin—coronary artery disease	0.00839	0.0334	CbGbCtD
Lurasidone—CYP3A4—Losartan—coronary artery disease	0.00767	0.0305	CbGbCtD
Lurasidone—HTR7—pulmonary artery—coronary artery disease	0.00457	0.0902	CbGeAlD
Lurasidone—HTR7—sympathetic nervous system—coronary artery disease	0.00445	0.0878	CbGeAlD
Lurasidone—HTR2A—arteriole—coronary artery disease	0.00435	0.0859	CbGeAlD
Lurasidone—HTR7—vagus nerve—coronary artery disease	0.00431	0.085	CbGeAlD
Lurasidone—HTR7—vein—coronary artery disease	0.00416	0.0821	CbGeAlD
Lurasidone—HTR7—autonomic nervous system—coronary artery disease	0.00299	0.059	CbGeAlD
Lurasidone—HTR2A—pulmonary artery—coronary artery disease	0.00285	0.0563	CbGeAlD
Lurasidone—HTR2A—sympathetic nervous system—coronary artery disease	0.00277	0.0547	CbGeAlD
Lurasidone—HTR2A—vagus nerve—coronary artery disease	0.00268	0.053	CbGeAlD
Lurasidone—HTR2A—vein—coronary artery disease	0.00259	0.0512	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—coronary artery disease	0.00186	0.0368	CbGeAlD
Lurasidone—HTR7—artery—coronary artery disease	0.00169	0.0335	CbGeAlD
Lurasidone—HTR7—endothelium—coronary artery disease	0.00143	0.0283	CbGeAlD
Lurasidone—HTR2A—artery—coronary artery disease	0.00106	0.0209	CbGeAlD
Lurasidone—HTR2A—endothelium—coronary artery disease	0.000893	0.0176	CbGeAlD
Lurasidone—ADRA2C—cardiac ventricle—coronary artery disease	0.000874	0.0172	CbGeAlD
Lurasidone—ADRA2C—myocardium—coronary artery disease	0.000822	0.0162	CbGeAlD
Lurasidone—Ziprasidone—HTR7—coronary artery disease	0.000777	0.665	CrCbGaD
Lurasidone—HTR7—heart—coronary artery disease	0.000624	0.0123	CbGeAlD
Lurasidone—HTR1A—cardiovascular system—coronary artery disease	0.000616	0.0122	CbGeAlD
Lurasidone—HTR7—cardiovascular system—coronary artery disease	0.000589	0.0116	CbGeAlD
Lurasidone—ADRA2C—heart—coronary artery disease	0.000574	0.0113	CbGeAlD
Lurasidone—ADRA2C—cardiac atrium—coronary artery disease	0.000491	0.00969	CbGeAlD
Lurasidone—HTR7—blood—coronary artery disease	0.000466	0.00919	CbGeAlD
Lurasidone—ADRA2A—heart—coronary artery disease	0.000458	0.00904	CbGeAlD
Lurasidone—ADRA2C—blood—coronary artery disease	0.000428	0.00845	CbGeAlD
Lurasidone—ADRA2A—cardiac atrium—coronary artery disease	0.000391	0.00773	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—coronary artery disease	0.00039	0.335	CrCbGaD
Lurasidone—HTR2A—heart—coronary artery disease	0.000389	0.00768	CbGeAlD
Lurasidone—HTR2A—cardiovascular system—coronary artery disease	0.000367	0.00725	CbGeAlD
Lurasidone—ADRA2A—blood—coronary artery disease	0.000342	0.00674	CbGeAlD
Lurasidone—HTR2A—blood—coronary artery disease	0.00029	0.00573	CbGeAlD
Lurasidone—CYP3A4—blood—coronary artery disease	0.000269	0.00531	CbGeAlD
Lurasidone—Gastrointestinal pain—Enalapril—coronary artery disease	8.07e-05	0.000413	CcSEcCtD
Lurasidone—Abdominal pain—Pravastatin—coronary artery disease	8.07e-05	0.000413	CcSEcCtD
Lurasidone—Hypotension—Losartan—coronary artery disease	8.06e-05	0.000412	CcSEcCtD
Lurasidone—Dizziness—Clopidogrel—coronary artery disease	8.03e-05	0.000411	CcSEcCtD
Lurasidone—Decreased appetite—Perindopril—coronary artery disease	7.99e-05	0.000409	CcSEcCtD
Lurasidone—Pruritus—Simvastatin—coronary artery disease	7.99e-05	0.000409	CcSEcCtD
Lurasidone—Dizziness—Lovastatin—coronary artery disease	7.98e-05	0.000409	CcSEcCtD
Lurasidone—Loss of consciousness—Ramipril—coronary artery disease	7.96e-05	0.000408	CcSEcCtD
Lurasidone—Gastrointestinal pain—Telmisartan—coronary artery disease	7.96e-05	0.000408	CcSEcCtD
Lurasidone—Vertigo—Timolol—coronary artery disease	7.96e-05	0.000407	CcSEcCtD
Lurasidone—Back pain—Lisinopril—coronary artery disease	7.95e-05	0.000407	CcSEcCtD
Lurasidone—Somnolence—Furosemide—coronary artery disease	7.94e-05	0.000407	CcSEcCtD
Lurasidone—Syncope—Timolol—coronary artery disease	7.94e-05	0.000407	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Perindopril—coronary artery disease	7.93e-05	0.000406	CcSEcCtD
Lurasidone—Diarrhoea—Eplerenone—coronary artery disease	7.93e-05	0.000406	CcSEcCtD
Lurasidone—Fatigue—Perindopril—coronary artery disease	7.92e-05	0.000406	CcSEcCtD
Lurasidone—Muscle spasms—Lisinopril—coronary artery disease	7.9e-05	0.000404	CcSEcCtD
Lurasidone—Vomiting—Fenofibrate—coronary artery disease	7.86e-05	0.000402	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Losartan—coronary artery disease	7.85e-05	0.000402	CcSEcCtD
Lurasidone—Convulsion—Ramipril—coronary artery disease	7.85e-05	0.000402	CcSEcCtD
Lurasidone—Abdominal pain—Trandolapril—coronary artery disease	7.83e-05	0.000401	CcSEcCtD
Lurasidone—Dizziness—Ezetimibe—coronary artery disease	7.83e-05	0.000401	CcSEcCtD
Lurasidone—Abdominal pain—Enalapril—coronary artery disease	7.8e-05	0.0004	CcSEcCtD
Lurasidone—Insomnia—Losartan—coronary artery disease	7.8e-05	0.000399	CcSEcCtD
Lurasidone—Rash—Fenofibrate—coronary artery disease	7.79e-05	0.000399	CcSEcCtD
Lurasidone—Dermatitis—Fenofibrate—coronary artery disease	7.78e-05	0.000399	CcSEcCtD
Lurasidone—Loss of consciousness—Timolol—coronary artery disease	7.78e-05	0.000399	CcSEcCtD
Lurasidone—Decreased appetite—Furosemide—coronary artery disease	7.77e-05	0.000398	CcSEcCtD
Lurasidone—Vision blurred—Lisinopril—coronary artery disease	7.74e-05	0.000396	CcSEcCtD
Lurasidone—Gastrointestinal pain—Captopril—coronary artery disease	7.74e-05	0.000396	CcSEcCtD
Lurasidone—Vomiting—Clopidogrel—coronary artery disease	7.72e-05	0.000396	CcSEcCtD
Lurasidone—Diarrhoea—Simvastatin—coronary artery disease	7.72e-05	0.000395	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Furosemide—coronary artery disease	7.71e-05	0.000395	CcSEcCtD
Lurasidone—Myalgia—Ramipril—coronary artery disease	7.71e-05	0.000395	CcSEcCtD
Lurasidone—Fatigue—Furosemide—coronary artery disease	7.7e-05	0.000394	CcSEcCtD
Lurasidone—Tremor—Lisinopril—coronary artery disease	7.7e-05	0.000394	CcSEcCtD
Lurasidone—Abdominal pain—Telmisartan—coronary artery disease	7.7e-05	0.000394	CcSEcCtD
Lurasidone—Dyspnoea—Losartan—coronary artery disease	7.69e-05	0.000394	CcSEcCtD
Lurasidone—Anxiety—Ramipril—coronary artery disease	7.68e-05	0.000393	CcSEcCtD
Lurasidone—Vomiting—Lovastatin—coronary artery disease	7.67e-05	0.000393	CcSEcCtD
Lurasidone—Somnolence—Losartan—coronary artery disease	7.66e-05	0.000392	CcSEcCtD
Lurasidone—Dizziness—Eplerenone—coronary artery disease	7.66e-05	0.000392	CcSEcCtD
Lurasidone—Rash—Clopidogrel—coronary artery disease	7.66e-05	0.000392	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.66e-05	0.000392	CcSEcCtD
Lurasidone—Dermatitis—Clopidogrel—coronary artery disease	7.65e-05	0.000392	CcSEcCtD
Lurasidone—Asthenia—Valsartan—coronary artery disease	7.65e-05	0.000392	CcSEcCtD
Lurasidone—Hypertension—Timolol—coronary artery disease	7.64e-05	0.000391	CcSEcCtD
Lurasidone—Asthenia—Olmesartan—coronary artery disease	7.61e-05	0.00039	CcSEcCtD
Lurasidone—Rash—Lovastatin—coronary artery disease	7.61e-05	0.00039	CcSEcCtD
Lurasidone—Dermatitis—Lovastatin—coronary artery disease	7.6e-05	0.000389	CcSEcCtD
Lurasidone—Anaemia—Lisinopril—coronary artery disease	7.59e-05	0.000389	CcSEcCtD
Lurasidone—Dyspepsia—Losartan—coronary artery disease	7.59e-05	0.000389	CcSEcCtD
Lurasidone—Pruritus—Valsartan—coronary artery disease	7.54e-05	0.000386	CcSEcCtD
Lurasidone—Dry mouth—Ramipril—coronary artery disease	7.54e-05	0.000386	CcSEcCtD
Lurasidone—Myalgia—Timolol—coronary artery disease	7.54e-05	0.000386	CcSEcCtD
Lurasidone—Vomiting—Ezetimibe—coronary artery disease	7.53e-05	0.000385	CcSEcCtD
Lurasidone—Gastrointestinal pain—Perindopril—coronary artery disease	7.52e-05	0.000385	CcSEcCtD
Lurasidone—Anxiety—Timolol—coronary artery disease	7.51e-05	0.000385	CcSEcCtD
Lurasidone—Angioedema—Lisinopril—coronary artery disease	7.51e-05	0.000384	CcSEcCtD
Lurasidone—Pruritus—Olmesartan—coronary artery disease	7.5e-05	0.000384	CcSEcCtD
Lurasidone—Decreased appetite—Losartan—coronary artery disease	7.49e-05	0.000384	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.49e-05	0.000383	CcSEcCtD
Lurasidone—Abdominal pain—Captopril—coronary artery disease	7.48e-05	0.000383	CcSEcCtD
Lurasidone—Dizziness—Simvastatin—coronary artery disease	7.46e-05	0.000382	CcSEcCtD
Lurasidone—Rash—Ezetimibe—coronary artery disease	7.46e-05	0.000382	CcSEcCtD
Lurasidone—Dermatitis—Ezetimibe—coronary artery disease	7.46e-05	0.000382	CcSEcCtD
Lurasidone—Asthenia—Niacin—coronary artery disease	7.44e-05	0.000381	CcSEcCtD
Lurasidone—Fatigue—Losartan—coronary artery disease	7.43e-05	0.000381	CcSEcCtD
Lurasidone—Malaise—Lisinopril—coronary artery disease	7.41e-05	0.000379	CcSEcCtD
Lurasidone—Vertigo—Lisinopril—coronary artery disease	7.38e-05	0.000378	CcSEcCtD
Lurasidone—Dry mouth—Timolol—coronary artery disease	7.37e-05	0.000378	CcSEcCtD
Lurasidone—Syncope—Lisinopril—coronary artery disease	7.37e-05	0.000377	CcSEcCtD
Lurasidone—Vomiting—Eplerenone—coronary artery disease	7.37e-05	0.000377	CcSEcCtD
Lurasidone—Leukopenia—Lisinopril—coronary artery disease	7.35e-05	0.000376	CcSEcCtD
Lurasidone—Nausea—Fenofibrate—coronary artery disease	7.34e-05	0.000376	CcSEcCtD
Lurasidone—Pruritus—Niacin—coronary artery disease	7.33e-05	0.000375	CcSEcCtD
Lurasidone—Asthenia—Pravastatin—coronary artery disease	7.32e-05	0.000375	CcSEcCtD
Lurasidone—Gastrointestinal pain—Furosemide—coronary artery disease	7.31e-05	0.000374	CcSEcCtD
Lurasidone—Rash—Eplerenone—coronary artery disease	7.3e-05	0.000374	CcSEcCtD
Lurasidone—Dermatitis—Eplerenone—coronary artery disease	7.3e-05	0.000374	CcSEcCtD
Lurasidone—Diarrhoea—Valsartan—coronary artery disease	7.29e-05	0.000373	CcSEcCtD
Lurasidone—Shock—Ramipril—coronary artery disease	7.27e-05	0.000372	CcSEcCtD
Lurasidone—Abdominal pain—Perindopril—coronary artery disease	7.27e-05	0.000372	CcSEcCtD
Lurasidone—Diarrhoea—Olmesartan—coronary artery disease	7.26e-05	0.000372	CcSEcCtD
Lurasidone—Nervous system disorder—Ramipril—coronary artery disease	7.25e-05	0.000371	CcSEcCtD
Lurasidone—Pruritus—Pravastatin—coronary artery disease	7.22e-05	0.00037	CcSEcCtD
Lurasidone—Loss of consciousness—Lisinopril—coronary artery disease	7.22e-05	0.00037	CcSEcCtD
Lurasidone—Nausea—Clopidogrel—coronary artery disease	7.22e-05	0.000369	CcSEcCtD
Lurasidone—Tachycardia—Ramipril—coronary artery disease	7.21e-05	0.000369	CcSEcCtD
Lurasidone—Skin disorder—Ramipril—coronary artery disease	7.18e-05	0.000368	CcSEcCtD
Lurasidone—Infection—Timolol—coronary artery disease	7.18e-05	0.000368	CcSEcCtD
Lurasidone—Vomiting—Simvastatin—coronary artery disease	7.18e-05	0.000367	CcSEcCtD
Lurasidone—Nausea—Lovastatin—coronary artery disease	7.17e-05	0.000367	CcSEcCtD
Lurasidone—Hyperhidrosis—Ramipril—coronary artery disease	7.15e-05	0.000366	CcSEcCtD
Lurasidone—Rash—Simvastatin—coronary artery disease	7.12e-05	0.000364	CcSEcCtD
Lurasidone—Dermatitis—Simvastatin—coronary artery disease	7.11e-05	0.000364	CcSEcCtD
Lurasidone—Asthenia—Trandolapril—coronary artery disease	7.11e-05	0.000364	CcSEcCtD
Lurasidone—Shock—Timolol—coronary artery disease	7.11e-05	0.000364	CcSEcCtD
Lurasidone—Diarrhoea—Niacin—coronary artery disease	7.09e-05	0.000363	CcSEcCtD
Lurasidone—Nervous system disorder—Timolol—coronary artery disease	7.09e-05	0.000363	CcSEcCtD
Lurasidone—Asthenia—Enalapril—coronary artery disease	7.08e-05	0.000363	CcSEcCtD
Lurasidone—Abdominal pain—Furosemide—coronary artery disease	7.06e-05	0.000362	CcSEcCtD
Lurasidone—Gastrointestinal pain—Losartan—coronary artery disease	7.05e-05	0.000361	CcSEcCtD
Lurasidone—Dizziness—Valsartan—coronary artery disease	7.05e-05	0.000361	CcSEcCtD
Lurasidone—Nausea—Ezetimibe—coronary artery disease	7.03e-05	0.00036	CcSEcCtD
Lurasidone—Skin disorder—Timolol—coronary artery disease	7.02e-05	0.000359	CcSEcCtD
Lurasidone—Dizziness—Olmesartan—coronary artery disease	7.01e-05	0.000359	CcSEcCtD
Lurasidone—Pruritus—Trandolapril—coronary artery disease	7.01e-05	0.000359	CcSEcCtD
Lurasidone—Myalgia—Lisinopril—coronary artery disease	6.99e-05	0.000358	CcSEcCtD
Lurasidone—Hyperhidrosis—Timolol—coronary artery disease	6.99e-05	0.000358	CcSEcCtD
Lurasidone—Asthenia—Telmisartan—coronary artery disease	6.98e-05	0.000358	CcSEcCtD
Lurasidone—Pruritus—Enalapril—coronary artery disease	6.98e-05	0.000358	CcSEcCtD
Lurasidone—Diarrhoea—Pravastatin—coronary artery disease	6.98e-05	0.000358	CcSEcCtD
Lurasidone—Anxiety—Lisinopril—coronary artery disease	6.97e-05	0.000357	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.94e-05	0.000356	CcSEcCtD
Lurasidone—Hypotension—Ramipril—coronary artery disease	6.91e-05	0.000354	CcSEcCtD
Lurasidone—Pruritus—Telmisartan—coronary artery disease	6.89e-05	0.000353	CcSEcCtD
Lurasidone—Nausea—Eplerenone—coronary artery disease	6.88e-05	0.000352	CcSEcCtD
Lurasidone—Dizziness—Niacin—coronary artery disease	6.85e-05	0.000351	CcSEcCtD
Lurasidone—Dry mouth—Lisinopril—coronary artery disease	6.84e-05	0.00035	CcSEcCtD
Lurasidone—Abdominal pain—Losartan—coronary artery disease	6.81e-05	0.000349	CcSEcCtD
Lurasidone—Asthenia—Captopril—coronary artery disease	6.79e-05	0.000348	CcSEcCtD
Lurasidone—Diarrhoea—Trandolapril—coronary artery disease	6.78e-05	0.000347	CcSEcCtD
Lurasidone—Vomiting—Valsartan—coronary artery disease	6.78e-05	0.000347	CcSEcCtD
Lurasidone—Diarrhoea—Enalapril—coronary artery disease	6.75e-05	0.000346	CcSEcCtD
Lurasidone—Hypotension—Timolol—coronary artery disease	6.75e-05	0.000346	CcSEcCtD
Lurasidone—Dizziness—Pravastatin—coronary artery disease	6.75e-05	0.000346	CcSEcCtD
Lurasidone—Vomiting—Olmesartan—coronary artery disease	6.74e-05	0.000345	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.73e-05	0.000345	CcSEcCtD
Lurasidone—Rash—Valsartan—coronary artery disease	6.72e-05	0.000344	CcSEcCtD
Lurasidone—Dermatitis—Valsartan—coronary artery disease	6.71e-05	0.000344	CcSEcCtD
Lurasidone—Nausea—Simvastatin—coronary artery disease	6.7e-05	0.000343	CcSEcCtD
Lurasidone—Pruritus—Captopril—coronary artery disease	6.7e-05	0.000343	CcSEcCtD
Lurasidone—Rash—Olmesartan—coronary artery disease	6.69e-05	0.000342	CcSEcCtD
Lurasidone—Insomnia—Ramipril—coronary artery disease	6.69e-05	0.000342	CcSEcCtD
Lurasidone—Dermatitis—Olmesartan—coronary artery disease	6.68e-05	0.000342	CcSEcCtD
Lurasidone—Diarrhoea—Telmisartan—coronary artery disease	6.66e-05	0.000341	CcSEcCtD
Lurasidone—Infection—Lisinopril—coronary artery disease	6.66e-05	0.000341	CcSEcCtD
Lurasidone—Shock—Lisinopril—coronary artery disease	6.6e-05	0.000338	CcSEcCtD
Lurasidone—Asthenia—Perindopril—coronary artery disease	6.59e-05	0.000338	CcSEcCtD
Lurasidone—Dyspnoea—Ramipril—coronary artery disease	6.59e-05	0.000337	CcSEcCtD
Lurasidone—Vomiting—Niacin—coronary artery disease	6.59e-05	0.000337	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Timolol—coronary artery disease	6.58e-05	0.000337	CcSEcCtD
Lurasidone—Somnolence—Ramipril—coronary artery disease	6.57e-05	0.000336	CcSEcCtD
Lurasidone—Dizziness—Trandolapril—coronary artery disease	6.55e-05	0.000336	CcSEcCtD
Lurasidone—Tachycardia—Lisinopril—coronary artery disease	6.54e-05	0.000335	CcSEcCtD
Lurasidone—Insomnia—Timolol—coronary artery disease	6.54e-05	0.000335	CcSEcCtD
Lurasidone—Rash—Niacin—coronary artery disease	6.53e-05	0.000335	CcSEcCtD
Lurasidone—Dermatitis—Niacin—coronary artery disease	6.53e-05	0.000334	CcSEcCtD
Lurasidone—Dizziness—Enalapril—coronary artery disease	6.53e-05	0.000334	CcSEcCtD
Lurasidone—Skin disorder—Lisinopril—coronary artery disease	6.51e-05	0.000333	CcSEcCtD
Lurasidone—Dyspepsia—Ramipril—coronary artery disease	6.51e-05	0.000333	CcSEcCtD
Lurasidone—Pruritus—Perindopril—coronary artery disease	6.5e-05	0.000333	CcSEcCtD
Lurasidone—Vomiting—Pravastatin—coronary artery disease	6.49e-05	0.000332	CcSEcCtD
Lurasidone—Hyperhidrosis—Lisinopril—coronary artery disease	6.48e-05	0.000332	CcSEcCtD
Lurasidone—Diarrhoea—Captopril—coronary artery disease	6.48e-05	0.000332	CcSEcCtD
Lurasidone—Dyspnoea—Timolol—coronary artery disease	6.44e-05	0.00033	CcSEcCtD
Lurasidone—Dizziness—Telmisartan—coronary artery disease	6.44e-05	0.00033	CcSEcCtD
Lurasidone—Rash—Pravastatin—coronary artery disease	6.43e-05	0.000329	CcSEcCtD
Lurasidone—Dermatitis—Pravastatin—coronary artery disease	6.43e-05	0.000329	CcSEcCtD
Lurasidone—Decreased appetite—Ramipril—coronary artery disease	6.43e-05	0.000329	CcSEcCtD
Lurasidone—Somnolence—Timolol—coronary artery disease	6.42e-05	0.000329	CcSEcCtD
Lurasidone—Asthenia—Furosemide—coronary artery disease	6.41e-05	0.000328	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Ramipril—coronary artery disease	6.38e-05	0.000327	CcSEcCtD
Lurasidone—Fatigue—Ramipril—coronary artery disease	6.37e-05	0.000326	CcSEcCtD
Lurasidone—Dyspepsia—Timolol—coronary artery disease	6.36e-05	0.000326	CcSEcCtD
Lurasidone—Nausea—Valsartan—coronary artery disease	6.33e-05	0.000324	CcSEcCtD
Lurasidone—Pruritus—Furosemide—coronary artery disease	6.32e-05	0.000324	CcSEcCtD
Lurasidone—Nausea—Olmesartan—coronary artery disease	6.3e-05	0.000323	CcSEcCtD
Lurasidone—Vomiting—Trandolapril—coronary artery disease	6.3e-05	0.000323	CcSEcCtD
Lurasidone—Diarrhoea—Perindopril—coronary artery disease	6.29e-05	0.000322	CcSEcCtD
Lurasidone—Decreased appetite—Timolol—coronary artery disease	6.28e-05	0.000322	CcSEcCtD
Lurasidone—Vomiting—Enalapril—coronary artery disease	6.28e-05	0.000321	CcSEcCtD
Lurasidone—Hypotension—Lisinopril—coronary artery disease	6.26e-05	0.000321	CcSEcCtD
Lurasidone—Dizziness—Captopril—coronary artery disease	6.26e-05	0.000321	CcSEcCtD
Lurasidone—Rash—Trandolapril—coronary artery disease	6.25e-05	0.00032	CcSEcCtD
Lurasidone—Dermatitis—Trandolapril—coronary artery disease	6.24e-05	0.00032	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Timolol—coronary artery disease	6.24e-05	0.000319	CcSEcCtD
Lurasidone—Fatigue—Timolol—coronary artery disease	6.23e-05	0.000319	CcSEcCtD
Lurasidone—Rash—Enalapril—coronary artery disease	6.22e-05	0.000319	CcSEcCtD
Lurasidone—Dermatitis—Enalapril—coronary artery disease	6.22e-05	0.000318	CcSEcCtD
Lurasidone—Vomiting—Telmisartan—coronary artery disease	6.19e-05	0.000317	CcSEcCtD
Lurasidone—Asthenia—Losartan—coronary artery disease	6.19e-05	0.000317	CcSEcCtD
Lurasidone—Nausea—Niacin—coronary artery disease	6.16e-05	0.000315	CcSEcCtD
Lurasidone—Rash—Telmisartan—coronary artery disease	6.14e-05	0.000314	CcSEcCtD
Lurasidone—Dermatitis—Telmisartan—coronary artery disease	6.13e-05	0.000314	CcSEcCtD
Lurasidone—Diarrhoea—Furosemide—coronary artery disease	6.11e-05	0.000313	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.11e-05	0.000313	CcSEcCtD
Lurasidone—Pruritus—Losartan—coronary artery disease	6.1e-05	0.000312	CcSEcCtD
Lurasidone—Dizziness—Perindopril—coronary artery disease	6.08e-05	0.000311	CcSEcCtD
Lurasidone—Insomnia—Lisinopril—coronary artery disease	6.06e-05	0.00031	CcSEcCtD
Lurasidone—Nausea—Pravastatin—coronary artery disease	6.06e-05	0.00031	CcSEcCtD
Lurasidone—Gastrointestinal pain—Ramipril—coronary artery disease	6.04e-05	0.00031	CcSEcCtD
Lurasidone—Vomiting—Captopril—coronary artery disease	6.02e-05	0.000308	CcSEcCtD
Lurasidone—Dyspnoea—Lisinopril—coronary artery disease	5.98e-05	0.000306	CcSEcCtD
Lurasidone—Rash—Captopril—coronary artery disease	5.97e-05	0.000306	CcSEcCtD
Lurasidone—Dermatitis—Captopril—coronary artery disease	5.96e-05	0.000305	CcSEcCtD
Lurasidone—Somnolence—Lisinopril—coronary artery disease	5.96e-05	0.000305	CcSEcCtD
Lurasidone—Gastrointestinal pain—Timolol—coronary artery disease	5.91e-05	0.000303	CcSEcCtD
Lurasidone—Dizziness—Furosemide—coronary artery disease	5.91e-05	0.000303	CcSEcCtD
Lurasidone—Dyspepsia—Lisinopril—coronary artery disease	5.9e-05	0.000302	CcSEcCtD
Lurasidone—Diarrhoea—Losartan—coronary artery disease	5.9e-05	0.000302	CcSEcCtD
Lurasidone—Nausea—Trandolapril—coronary artery disease	5.89e-05	0.000301	CcSEcCtD
Lurasidone—Nausea—Enalapril—coronary artery disease	5.86e-05	0.0003	CcSEcCtD
Lurasidone—Vomiting—Perindopril—coronary artery disease	5.84e-05	0.000299	CcSEcCtD
Lurasidone—Abdominal pain—Ramipril—coronary artery disease	5.84e-05	0.000299	CcSEcCtD
Lurasidone—Decreased appetite—Lisinopril—coronary artery disease	5.83e-05	0.000298	CcSEcCtD
Lurasidone—Rash—Perindopril—coronary artery disease	5.79e-05	0.000297	CcSEcCtD
Lurasidone—Dermatitis—Perindopril—coronary artery disease	5.79e-05	0.000296	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.79e-05	0.000296	CcSEcCtD
Lurasidone—Nausea—Telmisartan—coronary artery disease	5.78e-05	0.000296	CcSEcCtD
Lurasidone—Fatigue—Lisinopril—coronary artery disease	5.78e-05	0.000296	CcSEcCtD
Lurasidone—Abdominal pain—Timolol—coronary artery disease	5.71e-05	0.000293	CcSEcCtD
Lurasidone—Dizziness—Losartan—coronary artery disease	5.7e-05	0.000292	CcSEcCtD
Lurasidone—Vomiting—Furosemide—coronary artery disease	5.68e-05	0.000291	CcSEcCtD
Lurasidone—Rash—Furosemide—coronary artery disease	5.63e-05	0.000288	CcSEcCtD
Lurasidone—Dermatitis—Furosemide—coronary artery disease	5.63e-05	0.000288	CcSEcCtD
Lurasidone—Nausea—Captopril—coronary artery disease	5.62e-05	0.000288	CcSEcCtD
Lurasidone—Gastrointestinal pain—Lisinopril—coronary artery disease	5.48e-05	0.000281	CcSEcCtD
Lurasidone—Vomiting—Losartan—coronary artery disease	5.48e-05	0.000281	CcSEcCtD
Lurasidone—Nausea—Perindopril—coronary artery disease	5.46e-05	0.00028	CcSEcCtD
Lurasidone—Rash—Losartan—coronary artery disease	5.44e-05	0.000278	CcSEcCtD
Lurasidone—Dermatitis—Losartan—coronary artery disease	5.43e-05	0.000278	CcSEcCtD
Lurasidone—Nausea—Furosemide—coronary artery disease	5.31e-05	0.000272	CcSEcCtD
Lurasidone—Asthenia—Ramipril—coronary artery disease	5.3e-05	0.000272	CcSEcCtD
Lurasidone—Abdominal pain—Lisinopril—coronary artery disease	5.3e-05	0.000271	CcSEcCtD
Lurasidone—Pruritus—Ramipril—coronary artery disease	5.23e-05	0.000268	CcSEcCtD
Lurasidone—Asthenia—Timolol—coronary artery disease	5.18e-05	0.000265	CcSEcCtD
Lurasidone—Nausea—Losartan—coronary artery disease	5.12e-05	0.000262	CcSEcCtD
Lurasidone—Pruritus—Timolol—coronary artery disease	5.11e-05	0.000262	CcSEcCtD
Lurasidone—Diarrhoea—Ramipril—coronary artery disease	5.06e-05	0.000259	CcSEcCtD
Lurasidone—Diarrhoea—Timolol—coronary artery disease	4.94e-05	0.000253	CcSEcCtD
Lurasidone—Dizziness—Ramipril—coronary artery disease	4.89e-05	0.00025	CcSEcCtD
Lurasidone—Asthenia—Lisinopril—coronary artery disease	4.81e-05	0.000246	CcSEcCtD
Lurasidone—Dizziness—Timolol—coronary artery disease	4.78e-05	0.000245	CcSEcCtD
Lurasidone—Pruritus—Lisinopril—coronary artery disease	4.74e-05	0.000243	CcSEcCtD
Lurasidone—Vomiting—Ramipril—coronary artery disease	4.7e-05	0.000241	CcSEcCtD
Lurasidone—Rash—Ramipril—coronary artery disease	4.66e-05	0.000239	CcSEcCtD
Lurasidone—Dermatitis—Ramipril—coronary artery disease	4.66e-05	0.000238	CcSEcCtD
Lurasidone—Vomiting—Timolol—coronary artery disease	4.59e-05	0.000235	CcSEcCtD
Lurasidone—Diarrhoea—Lisinopril—coronary artery disease	4.59e-05	0.000235	CcSEcCtD
Lurasidone—Rash—Timolol—coronary artery disease	4.56e-05	0.000233	CcSEcCtD
Lurasidone—Dermatitis—Timolol—coronary artery disease	4.55e-05	0.000233	CcSEcCtD
Lurasidone—Dizziness—Lisinopril—coronary artery disease	4.43e-05	0.000227	CcSEcCtD
Lurasidone—Nausea—Ramipril—coronary artery disease	4.39e-05	0.000225	CcSEcCtD
Lurasidone—Nausea—Timolol—coronary artery disease	4.29e-05	0.00022	CcSEcCtD
Lurasidone—Vomiting—Lisinopril—coronary artery disease	4.26e-05	0.000218	CcSEcCtD
Lurasidone—Rash—Lisinopril—coronary artery disease	4.23e-05	0.000216	CcSEcCtD
Lurasidone—Dermatitis—Lisinopril—coronary artery disease	4.22e-05	0.000216	CcSEcCtD
Lurasidone—Nausea—Lisinopril—coronary artery disease	3.98e-05	0.000204	CcSEcCtD
Lurasidone—ADRA2C—Signaling Pathways—IL6ST—coronary artery disease	4.25e-06	4.36e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ALB—coronary artery disease	4.23e-06	4.35e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	4.23e-06	4.34e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—KIT—coronary artery disease	4.22e-06	4.33e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NFKBIA—coronary artery disease	4.21e-06	4.33e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HIF1A—coronary artery disease	4.2e-06	4.31e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CXCL8—coronary artery disease	4.19e-06	4.3e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AGT—coronary artery disease	4.19e-06	4.3e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HIF1A—coronary artery disease	4.13e-06	4.25e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	4.13e-06	4.24e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AGT—coronary artery disease	4.12e-06	4.23e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	4.11e-06	4.22e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—LEP—coronary artery disease	4.1e-06	4.21e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOE—coronary artery disease	4.1e-06	4.21e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—KIT—coronary artery disease	4.08e-06	4.19e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOA1—coronary artery disease	4.06e-06	4.16e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—NOS3—coronary artery disease	4.05e-06	4.16e-05	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—AKT1—coronary artery disease	4.05e-06	4.16e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	4.05e-06	4.15e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—LEP—coronary artery disease	4.04e-06	4.14e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOE—coronary artery disease	4.04e-06	4.14e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	4.04e-06	4.14e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—KDR—coronary artery disease	4.02e-06	4.13e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—POMC—coronary artery disease	4.01e-06	4.12e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CREB1—coronary artery disease	4.01e-06	4.12e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CASP3—coronary artery disease	4.01e-06	4.12e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—VCAN—coronary artery disease	4.01e-06	4.11e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MAPK14—coronary artery disease	3.99e-06	4.1e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOA1—coronary artery disease	3.99e-06	4.1e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6—coronary artery disease	3.98e-06	4.09e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.97e-06	4.08e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—KDR—coronary artery disease	3.95e-06	4.06e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	3.95e-06	4.06e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—C3—coronary artery disease	3.94e-06	4.05e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	3.93e-06	4.03e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCL2—coronary artery disease	3.93e-06	4.03e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ESR1—coronary artery disease	3.92e-06	4.02e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—GSK3B—coronary artery disease	3.92e-06	4.02e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6R—coronary artery disease	3.92e-06	4.02e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CCND1—coronary artery disease	3.9e-06	4.01e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—POMC—coronary artery disease	3.88e-06	3.99e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CREB1—coronary artery disease	3.88e-06	3.99e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—F2—coronary artery disease	3.87e-06	3.97e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FN1—coronary artery disease	3.87e-06	3.97e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF1—coronary artery disease	3.86e-06	3.96e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—DCN—coronary artery disease	3.86e-06	3.96e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ESR1—coronary artery disease	3.85e-06	3.96e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6ST—coronary artery disease	3.85e-06	3.96e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	3.84e-06	3.95e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PPARG—coronary artery disease	3.83e-06	3.93e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	3.82e-06	3.92e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—F2—coronary artery disease	3.81e-06	3.91e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FN1—coronary artery disease	3.81e-06	3.91e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL2—coronary artery disease	3.8e-06	3.9e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	3.79e-06	3.89e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MMP9—coronary artery disease	3.79e-06	3.89e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6R—coronary artery disease	3.79e-06	3.89e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—POMC—coronary artery disease	3.77e-06	3.87e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	3.76e-06	3.86e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	3.76e-06	3.86e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.75e-06	3.85e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AGT—coronary artery disease	3.75e-06	3.85e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF1—coronary artery disease	3.74e-06	3.84e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—AKT1—coronary artery disease	3.73e-06	3.83e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—MAPK1—coronary artery disease	3.72e-06	3.82e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTGS2—coronary artery disease	3.7e-06	3.8e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—KIT—coronary artery disease	3.7e-06	3.8e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AKT1—coronary artery disease	3.68e-06	3.77e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—LEP—coronary artery disease	3.67e-06	3.77e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOE—coronary artery disease	3.67e-06	3.77e-05	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.67e-06	3.77e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	3.67e-06	3.76e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.66e-06	3.76e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HBA1—coronary artery disease	3.66e-06	3.76e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.66e-06	3.76e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LIPC—coronary artery disease	3.66e-06	3.76e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—KIT—coronary artery disease	3.64e-06	3.74e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOC3—coronary artery disease	3.64e-06	3.73e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	3.63e-06	3.73e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LDLR—coronary artery disease	3.61e-06	3.71e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—KDR—coronary artery disease	3.6e-06	3.69e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	3.57e-06	3.67e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.57e-06	3.67e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.57e-06	3.67e-05	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	3.55e-06	3.65e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—GSK3B—coronary artery disease	3.55e-06	3.65e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FGF2—coronary artery disease	3.55e-06	3.64e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	3.55e-06	3.64e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCLC—coronary artery disease	3.53e-06	3.62e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CETP—coronary artery disease	3.53e-06	3.62e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—POMC—coronary artery disease	3.52e-06	3.62e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CREB1—coronary artery disease	3.52e-06	3.62e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	3.51e-06	3.6e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NOS3—coronary artery disease	3.5e-06	3.59e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	3.5e-06	3.59e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SDC1—coronary artery disease	3.49e-06	3.58e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—POMC—coronary artery disease	3.47e-06	3.56e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CREB1—coronary artery disease	3.47e-06	3.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—F2—coronary artery disease	3.46e-06	3.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FN1—coronary artery disease	3.46e-06	3.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	3.45e-06	3.54e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL2—coronary artery disease	3.45e-06	3.54e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ALB—coronary artery disease	3.44e-06	3.53e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6R—coronary artery disease	3.44e-06	3.53e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	3.43e-06	3.53e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	3.42e-06	3.51e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—VEGFA—coronary artery disease	3.4e-06	3.49e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—JAK2—coronary artery disease	3.4e-06	3.49e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL2—coronary artery disease	3.39e-06	3.48e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF1—coronary artery disease	3.39e-06	3.48e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	3.39e-06	3.48e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6R—coronary artery disease	3.38e-06	3.47e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	3.37e-06	3.46e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF1—coronary artery disease	3.34e-06	3.42e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.33e-06	3.42e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	3.32e-06	3.41e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—KIT—coronary artery disease	3.31e-06	3.4e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.3e-06	3.38e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.3e-06	3.38e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	3.29e-06	3.38e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—NOS3—coronary artery disease	3.29e-06	3.38e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	3.23e-06	3.31e-05	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	3.22e-06	3.31e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CTGF—coronary artery disease	3.22e-06	3.31e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	3.22e-06	3.31e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.19e-06	3.28e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GOT2—coronary artery disease	3.19e-06	3.28e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	3.18e-06	3.27e-05	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	3.17e-06	3.26e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	3.17e-06	3.25e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—POMC—coronary artery disease	3.15e-06	3.24e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	3.15e-06	3.24e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TGFB1—coronary artery disease	3.12e-06	3.21e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FGF2—coronary artery disease	3.12e-06	3.2e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	3.1e-06	3.19e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	3.09e-06	3.17e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	3.08e-06	3.16e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NOS3—coronary artery disease	3.07e-06	3.16e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FGF2—coronary artery disease	3.07e-06	3.15e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MAPK1—coronary artery disease	3.06e-06	3.15e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	3.03e-06	3.12e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NOS3—coronary artery disease	3.02e-06	3.1e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	3.02e-06	3.1e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTGS2—coronary artery disease	3.01e-06	3.09e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	3e-06	3.08e-05	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	3e-06	3.08e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—JAK2—coronary artery disease	2.99e-06	3.07e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CASP3—coronary artery disease	2.97e-06	3.05e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—coronary artery disease	2.95e-06	3.03e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—JAK2—coronary artery disease	2.94e-06	3.02e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.93e-06	3.01e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	2.93e-06	3.01e-05	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	2.9e-06	2.98e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCND1—coronary artery disease	2.89e-06	2.97e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.89e-06	2.96e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	2.88e-06	2.96e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.88e-06	2.96e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	2.88e-06	2.95e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	2.86e-06	2.93e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.84e-06	2.92e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MMP9—coronary artery disease	2.81e-06	2.88e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	2.8e-06	2.87e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	2.79e-06	2.86e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GOT1—coronary artery disease	2.75e-06	2.83e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GGT1—coronary artery disease	2.75e-06	2.83e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	2.75e-06	2.82e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CXCL8—coronary artery disease	2.73e-06	2.8e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	2.72e-06	2.8e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	2.72e-06	2.79e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	2.68e-06	2.75e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	2.67e-06	2.75e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	2.66e-06	2.73e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	2.64e-06	2.71e-05	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	2.63e-06	2.7e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.62e-06	2.69e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CASP3—coronary artery disease	2.61e-06	2.68e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—coronary artery disease	2.59e-06	2.66e-05	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	2.59e-06	2.66e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CASP3—coronary artery disease	2.57e-06	2.64e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—coronary artery disease	2.55e-06	2.62e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCND1—coronary artery disease	2.54e-06	2.61e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	2.52e-06	2.59e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCND1—coronary artery disease	2.5e-06	2.57e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.47e-06	2.54e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MMP9—coronary artery disease	2.47e-06	2.53e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.45e-06	2.52e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.44e-06	2.51e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	2.44e-06	2.51e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	2.44e-06	2.51e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MMP9—coronary artery disease	2.43e-06	2.49e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CAT—coronary artery disease	2.41e-06	2.47e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AKT1—coronary artery disease	2.39e-06	2.46e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	2.36e-06	2.42e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—coronary artery disease	2.35e-06	2.42e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	2.35e-06	2.42e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOB—coronary artery disease	2.34e-06	2.4e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	2.34e-06	2.4e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	2.32e-06	2.38e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	2.31e-06	2.38e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PIK3CA—coronary artery disease	2.28e-06	2.34e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.27e-06	2.33e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	2.27e-06	2.33e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	2.27e-06	2.33e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	2.24e-06	2.3e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LPL—coronary artery disease	2.23e-06	2.29e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—VEGFA—coronary artery disease	2.21e-06	2.27e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	2.21e-06	2.27e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	2.2e-06	2.26e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	2.18e-06	2.24e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX1—coronary artery disease	2.18e-06	2.24e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AKT1—coronary artery disease	2.17e-06	2.23e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	2.14e-06	2.2e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CD36—coronary artery disease	2.12e-06	2.18e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.09e-06	2.15e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TGFB1—coronary artery disease	2.03e-06	2.09e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.01e-06	2.06e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	2e-06	2.05e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.99e-06	2.05e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	1.98e-06	2.04e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	1.97e-06	2.02e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.96e-06	2.01e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AGT—coronary artery disease	1.91e-06	1.96e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	1.91e-06	1.96e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOE—coronary artery disease	1.87e-06	1.92e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—AKT1—coronary artery disease	1.86e-06	1.91e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3CA—coronary artery disease	1.85e-06	1.9e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOA1—coronary artery disease	1.85e-06	1.9e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	1.82e-06	1.87e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	1.78e-06	1.83e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—coronary artery disease	1.74e-06	1.79e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	1.73e-06	1.78e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	1.7e-06	1.75e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—coronary artery disease	1.69e-06	1.73e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARG—coronary artery disease	1.63e-06	1.67e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT1—coronary artery disease	1.61e-06	1.65e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—POMC—coronary artery disease	1.61e-06	1.65e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	1.56e-06	1.6e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	1.55e-06	1.59e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—coronary artery disease	1.53e-06	1.57e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AKT1—coronary artery disease	1.51e-06	1.55e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—coronary artery disease	1.51e-06	1.55e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALB—coronary artery disease	1.47e-06	1.5e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT1—coronary artery disease	1.41e-06	1.45e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NOS3—coronary artery disease	1.4e-06	1.44e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT1—coronary artery disease	1.39e-06	1.43e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—coronary artery disease	1.37e-06	1.41e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.28e-06	1.32e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	1.26e-06	1.3e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.89e-07	8.1e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AKT1—coronary artery disease	6.44e-07	6.62e-06	CbGpPWpGaD
